# FDA Inspection 1026913 - Vitalant - September 19, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/16d480ec-26f1-4a1a-9dbf-22cdf5620ee6
Source feed: FDA_Inspections

> FDA Inspection 1026913 for Vitalant on September 19, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1026913
- Company Name: Vitalant
- Inspection Date: 2017-09-19
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1160529 - 2021-12-14](https://www.keypedia.com/records/fda_inspections/vitalant/95be3d80-f396-43c2-930b-191a875a3ecf)
- [FDA Inspection 1160529 - 2021-12-14](https://www.keypedia.com/records/fda_inspections/vitalant/031b4059-0405-4e10-b62a-b40a6d032331)
- [FDA Inspection 942097 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/vitalant/c43f1e04-ae2c-4442-9c64-16dab1ce751c)
- [FDA Inspection 817692 - 2013-02-08](https://www.keypedia.com/records/fda_inspections/vitalant/74f54868-2684-4a56-8749-1c1d2065c851)
- [FDA Inspection 711383 - 2011-02-03](https://www.keypedia.com/records/fda_inspections/vitalant/aea6223d-2811-46f0-923a-e347a21372b8)

Company: https://www.keypedia.com/companies/vitalant/fc681fe8-2204-41bf-bcce-919a7fa25cec

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d